CDEK
← All drugs Report issue

pf-00547659

mAbexperimental

Clinical trial activity

5 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2005 (NCT00928681)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • pf-00547659
  • pf-00547659
  • pf-00547659

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01771809Phase 2Mar 1, 2013Shire
NCT01620255Phase 2Nov 1, 2012Pfizer, Shire
NCT01298492Phase 2Jul 1, 2011Pfizer
NCT01276509Phase 2Apr 6, 2011Pfizer, Shire
NCT00928681Phase 1Sep 1, 2005Pfizer
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit4222005
ShireFor profit3312011
2 organizations
Page 1 / 1